Evidence map›Paper›PMID 35505357›Full record

ReviewStem cell research & therapy2022

Stem cell therapy for vocal fold regeneration after scarring: a review of experimental approaches.

Mikhail V Svistushkin, Svetlana Kotova, Anastasia Shpichka, Svetlana Starostina, Anatoliy Shekhter, Polina Bikmulina, Anna Nikiforova, Anna Zolotova, Valery Royuk, P A Kochetkov and 5 more

Abstract readReview
In one paragraph

Review in Stem cell research & therapy, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Mikhail V SvistushkinDepartment for ENT Diseases, Sechenov University, Moscow, Russia.
Svetlana KotovaInstitute for Regenerative Medicine, Sechenov University, Moscow, Russia.
Anastasia ShpichkaWorld-Class Research Center "Digital Biodesign and Personalized Healthcare", Sechenov University, Moscow, Russia. ana-shpichka@yandex.ru.ORCID 0000-0002-9918-9979
Svetlana StarostinaDepartment for ENT Diseases, Sechenov University, Moscow, Russia.
Anatoliy ShekhterInstitute for Regenerative Medicine, Sechenov University, Moscow, Russia.
Polina BikmulinaWorld-Class Research Center "Digital Biodesign and Personalized Healthcare", Sechenov University, Moscow, Russia.
Anna NikiforovaDepartment for ENT Diseases, Sechenov University, Moscow, Russia.
Anna ZolotovaDepartment for ENT Diseases, Sechenov University, Moscow, Russia.
Valery RoyukUniversity Hospital No 1, Sechenov University, Moscow, Russia.
P A KochetkovDepartment for ENT Diseases, Sechenov University, Moscow, Russia.
Serge TimashevNational Research Nuclear University «MEPhI», Moscow, Russia.
Victor FominDepartment of Internal Medicine No 1, Sechenov University, Moscow, Russia.
Massoud VosoughDepartment of Regenerative Medicine, Cell Science Research Center, Royan Institute for Stem Cell Biology and Technology, ACECR, Tehran, Iran. masvos@Royaninstitute.org.
Valery SvistushkinDepartment for ENT Diseases, Sechenov University, Moscow, Russia.
Peter TimashevWorld-Class Research Center "Digital Biodesign and Personalized Healthcare", Sechenov University, Moscow, Russia. timashev_p_s@staff.sechenov.ru.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This review aims at becoming a guide which will help to plan the experimental design and to choose adequate methods to assess the outcomes when testing cell-based products in the treatment of the damaged vocal folds. The requirements to preclinical trials of cell-based products remain rather hazy and dictated by the country regulations. Most parameters like the way the cells are administered, selection of the cell source, selection of a carrier, and design of in vivo studies are decided upon by each research team and may differ essentially between studies. The review covers the methodological aspects of preclinical studies such as experimental models, characterization of cell products, assessment of the study outcome using molecular, morphological and immunohistochemical analyses, as well as measuring the tissue physical properties. The unified recommendations to perform preclinical trials could significantly facilitate the translation of cell-based products into the clinical practice.

Indexed as

CicatrixVocal CordsHumansStem Cell TransplantationCell therapyExperimental studiesMesenchymal stromal cellsScarringVocal folds

Identifiers

PMID35505357
PMCPMC9066721

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.